Since filaggrin loss-of-function mutations were first described by Palmer et al. [5] as a major predisposing factor for AD, filaggrin has probably received the most attention for its contributions to skin barrier function, dysfunction, and TEWL [44,45,46,47,48,49,50,51]. This evidence concerns the gene FLG and Alzheimer disease.